VaramirStart free · no cardSign in
IMNM as of Nov 1 · 04:54 ET
IMNMNasdaqPharmaceutical Preparations

Immunome Inc. · Brief

Next report

4 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±20.1%
avg realized
±4.3%
Jan 29 '25±52.3%▲+12.41%×0.24
Mar 19 '25±12.3%▲+1.05%×0.09
May 12 '25±18.6%▼−0.38%×0.02
Aug 6 '25±12.3%▼−5.64%×0.46
Q3 FY25±30.1%▼−1.68%×0.06
Q1 FY26±9.3%▲+4.55%×0.49
May 12 '26±7.4%▼−2.16%×0.29
Q2 FY26±18.3%▲+6.63%×0.36
quarterimplied−55%0+55%realized×
Q2 FY26±18.3%▲+6.63%×0.36
May '26±7.4%▼−2.16%×0.29
Q1 FY26±9.3%▲+4.55%×0.49
Q3 FY25±30.1%▼−1.68%×0.06
Aug '25±12.3%▼−5.64%×0.46
May '25±18.6%▼−0.38%×0.02
2 older reports
Mar '25±12.3%▲+1.05%×0.09
Jan '25±52.3%▲+12.41%×0.24
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

5disclosed supplier and customer ties in SEC filingsSEC filings
203managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

6 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
8 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

IMNM report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±21.3% into Nov 5 earnings (Oct 22 close).Source
Oct 58-KMaterial agreement: Amendment to License Agreement; Stock Issuance Agreement with Bristol-Myers Squibb Company.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.